Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Long Term Incentive Plan - Replacement

8 Dec 2010 16:35

RNS Number : 6238X
Swallowfield PLC
08 December 2010
 



The following amendment has been made to the 'Long Term Incentive Plan'

announcement released on Wednesday 8 December 2010 at 14.56 under RNS No 6143X.

 

The award is linked to post tax earnings not pre tax earnings as previously announced.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Swallowfield plc

Long Term Incentive Plan

Swallowfield plc ("the Company") announced on 8 March 2010, the introduction of a new long term incentive plan, the Swallowfield plc 2009 Long Term Incentive Plan ("LTIP") to incentivise its senior management team to maximise shareholder value.

The Company announces that it has made further awards pursuant to the LTIP of 58,983; 27,331; and 27,331 shares to Ian Mackinnon, Mark Warren and Jane Fletcher (directors of the Company) respectively. The Remuneration Committee has determined that the vesting of these awards should be linked to, and be conditional upon, the compound growth in the Company's post tax earnings per share over a three year cycle measured by reference to the last full year audited results, which for the purpose of this award be those for the year ended 30 June 2010. The minimum hurdle, below which no awards will vest, equates to 15% annual growth (excluding inflation) at which level 25% of the awards will vest. The maximum award equates to 25% annual growth (excluding inflation) with the percentage of awards vesting being pro-rated between these levels. Upon vesting, half of each award will be made in shares, which the recipient will be required to hold for 12 months, and the balance in cash.

Following the grant of the awards, the aforementioned directors have the following interests in the Company's share capital:

Number of issued Ordinary Shares

Percentage of issued share capital

Number of awards issued under the LTIP

Ian Mackinnon

135,500

1.2%

135,546

Mark Warren

22,100

0.2%

60,144

Jane Fletcher

25,000

0.2%

62,878

Enquiries:

Swallowfield plc

01823 652241

Ian Mackinnon - Chief Executive Officer

Mark Warren - Group Finance Director

Smith & Williamson Corporate Finance Limited

0117 376 2213

Broking - Barrie Newton

Nominated Adviser - Nick Reeve/Martyn Fraser

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLRFALTIII
Date   Source Headline
13th Apr 20225:19 pmRNSForm 8.3 - Brand Architekts Group PLC
13th Apr 20224:03 pmRNSForm 8.3 - Offeree - InnovaDerma PLC
13th Apr 20223:22 pmGNWForm 8.3 - Brand Architekts Group plc
13th Apr 20229:26 amRNSForm 8.3 - Brand Architekts Group Plc
13th Apr 20228:48 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
12th Apr 20223:21 pmRNSForm 8.3 - Brand Architekts Group plc - Replace
12th Apr 20222:04 pmRNSForm 8.5 (EPT/RI)
12th Apr 20229:34 amRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:18 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:17 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:14 pmRNSForm 8 (OPD) InnovaDerma PLC
11th Apr 20226:10 pmRNSForm 8 (OPD) - Brand Architekts plc
11th Apr 20224:04 pmRNSForm 8.3 - Brand Architekts Group PLC
11th Apr 20229:06 amRNSForm 8.5 (EPT/RI)
8th Apr 20225:15 pmRNSForm 8.3 - Brand Architekts Group PLC
8th Apr 202210:31 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
7th Apr 20222:40 pmRNSForm 8.4 - Roger McDowell
7th Apr 20222:40 pmRNSDirector/PDMR Shareholding
7th Apr 20229:53 amRNSForm 8.5 (EPT/RI)
6th Apr 20221:10 pmRNSForm 8.4 - Roger McDowell
6th Apr 20221:00 pmRNSDirector/PDMR Shareholding
6th Apr 202211:00 amRNSForm 8.3 - Brand Architekts Group PLC
6th Apr 202210:56 amRNSForm 8.5 (EPT/RI)
5th Apr 202211:45 amRNSForm 8.5 (EPT/RI)
4th Apr 202211:18 amRNSForm 8.5 (EPT/RI)
1st Apr 20221:40 pmRNSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
1st Apr 202211:53 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
31st Mar 20222:54 pmRNSForm 8.3 - Brand Architekts Group Plc
31st Mar 20221:26 pmGNWForm 8.3 - Octopus Investments - Brand Architekts Group plc
31st Mar 20229:52 amBUSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
31st Mar 20227:01 amRNSRecommended Merger with InnovaDerma Plc
31st Mar 20227:00 amRNSHalf-year Report
1st Mar 20227:00 amRNSBoard Appointment
14th Feb 202210:07 amRNSHolding(s) in Company
6th Dec 20214:01 pmRNSHolding(s) in Company
6th Dec 20213:56 pmRNSHolding(s) in Company
29th Nov 20213:54 pmRNSResult of AGM
4th Nov 20213:25 pmRNSAnnual Report and Accounts & Notice of AGM
12th Oct 202112:40 pmRNSGrant of Options
6th Oct 20213:51 pmRNSHolding(s) in Company
5th Oct 202111:23 amRNSHolding(s) in Company
4th Oct 20212:31 pmRNSHolding(s) in Company
30th Sep 202110:23 amRNSLaunch of marketplace: The Unexpekted Store
28th Sep 20212:56 pmRNSDirector/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results
16th Sep 20217:00 amRNSNotice of Investor Presentation
20th Jul 20217:00 amRNSTrading Update
2nd Jul 202110:57 amRNSHolding(s) in Company
29th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.